◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

IOVANCE BIOTHERAPEUTICS, INC.

IOVANCE BIOTHERAPEUTICS, INC.
SAN CARLOS, CA
Loading...
Price History
Market Data
Market Cap1.63B
P/E Ratio-
P/B Ratio2.33
EPS-
Dividend Yield-
D/E Ratio0.31
Current Ratio3.20
CurrencyUSD
Key Financial Metrics
263.50M
Revenue
-390.98M
Net Income
-
EPS (Diluted)
-630.96M
Free Cash Flow
Profitability
Gross Margin 28.7%
Operating Margin -153.1%
Net Profit Margin -148.4%
EBITDA -384.31M
Returns & Efficiency
Return on Assets (ROA) -42.8%
Return on Equity (ROE) -56.0%
Dividend Yield -
EPS -
Financial Health
Total Assets 913.17M
Total Debt -
Debt to Equity 0.31x
Current Ratio 3.20
Insider Trading Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report

Loading...

10-Q
Quarterly Report

Loading...

8-K
Recent News

Loading...

Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
IndustryChemicals & Allied Products
HQSAN CARLOS, CA
Fiscal Year2025
Peers
AMGEN INC
AMGN
177.13B
P/E: --
166.13B
P/E: --
166.13B
P/E: --
27.90B
P/E: --
27.90B
P/E: --
19.11B
P/E: --
18.38B
P/E: --
18.38B
P/E: --
Financial Statistics
Valuation
Market Cap$1.63B
P/E Ratio (TTM)-
Price to Book2.33
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin28.7%
Operating Margin-153.1%
Net Margin-148.4%
ROE-56.0%
ROA-42.8%
Leverage & Liquidity
Debt to Equity0.31
Current Ratio3.20
Total Debt-
Total Assets$913.17M
Stockholders' Equity$698.58M
Income Statement (FY 2025)
Revenue$263.50M
Gross Profit$75.51M
Operating Income$-403.36M
Net Income$-390.98M
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$-630.96M
Cash & Equivalents$163.08M
Revenue Growth60.6%
SEC Filings by Category
Insider Trading Activity
Neutral 0 Buys $0 0 Sales $0 0 Exercises $0 Net: $0
InsiderTitleDateTypeSharesPriceValue
Company Information
Business Address825 INDUSTRIAL ROAD
4TH FLOOR
SAN CARLOS, CA 94070
Phone6502607120
IncorporatedDE, US
EIN753254381
Fiscal Year End1231
Shares Outstanding411.96M
Stockholders' Equity$698.58M
Cash & Equivalents$163.08M
Recent Filings View All
DEFA14A Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-28
Local
DEF 14A Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-28
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-26
Local
8-K Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-24
Local
10-K Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-24
Local
Loading...

Loading management data...

Loading...

Loading board of directors...

Loading...

Loading institutional holders...

Loading...

Loading short interest data...

Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
Company NameIOVANCE BIOTHERAPEUTICS, INC.
TickerIOVA
Exchange--
SectorManufacturing
IndustryChemicals & Allied Products
HeadquartersSAN CARLOS, CA
Fiscal Year2025
Financial Summary
Market Cap1.63B
Revenue263.50M
Net Income-390.98M
P/E Ratio-
EPS-
Net Margin-148.4%
ROE-56.0%
Dividend Yield-
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...